Compare Extra Space Storage, Inc. (EXR) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Extra Space Storage, Inc. vs Novo Nordisk A/S — how do they compare? Extra Space Storage, Inc. trades at $134.3 (market cap $28.12B), while Novo Nordisk A/S trades at $38.51 (market cap $165.31B). The key difference: Novo Nordisk A/S is far larger — about 5.9× Extra Space Storage, Inc.'s market cap, and Extra Space Storage, Inc. pays the higher dividend (4.87%). Which is the better fit depends on your goals — on Pluang, investors hold Extra Space Storage, Inc. for 109 Days and Novo Nordisk A/S for 116 Days on average.
| EXR | NVO | |
|---|---|---|
Market Cap | $28.12B | $165.31B |
Volume | 2,595,579 | 11,432,838 |
Sector | Real Estate | Health |
52-Week High | $152.85 | $63.98 |
52-Week Low | $126.67 | $35.29 |
Typical Hold Time | 109 Days | 116 Days |
Enterprise Value | $41.84B | $179.56B |
Dividend Yield | 4.87% | 4.71% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Extra Space Storage (EXR) trades at $134.22, up 1.91% today, with a bearish technical signal but strong fundamentals including a 27.79% net income margin and consistent earnings beats. The company reported $3.38B in 2025 revenue, with a P/E of 29.39 and a consensus price target of $158.33. Recent news highlights executive leadership transition and a Q3 2026 earnings call scheduled for October 27, 2026.
Outlook is mixed: analyst consensus is evenly split between Buy and Hold, with upside potential from operational strength, but risks include high debt levels and bearish technical indicators. The stock offers a dividend yield supported by stable cash flows, though macroeconomic sensitivity and valuation premiums warrant caution.
Novo Nordisk (NVO) trades at $38.41, up 0.38% with strong fundamentals including 35.35% net margin and consistent earnings beats. The stock shows bearish technical signals but maintains robust profitability with $102.43B net income. Recent news highlights pipeline developments including Wegovy pill data and FDA reviews, while competition with Eli Lilly intensifies in the obesity drug market.
NVO presents a compelling value opportunity with a 9.66 P/E ratio and 59% upside to the $44.67 consensus target. However, technical weakness and competitive pressures from Lilly's new drug candidates pose near-term risks. The company's strong cash flow generation and 59.82% ROE support long-term growth prospects despite regulatory uncertainties.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Extra Space Storage, Inc.
Extra Space Storage is a fully integrated real estate investment trust that owns, operates, and manages almost 2,100 self-storage properties in 41 states, with over 160 million net rentable square feet of storage space. Of these properties, approximately one half is wholly owned, while some facilities are owned through joint ventures and others are owned by third parties and managed by Extra Space Storage in exchange for a management fee.
Read more on EXR →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
